Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Alzheon
AddedFeb 15, 2024
UpdatedJun 18, 2026
Alzheon

Alzheon

Alzheon: A Framingham-based biopharmaceutical firm developing treatments for neurological disorders.

HQ
Framingham, MA, US
Founded
2013
Overview
Compare
Fundraising
Employees
News
Website

Founded in 2013, Alzheon is a clinical-stage biopharmaceutical company headquartered in Framingham, Massachusetts. The company's core mission is to develop innovative treatments for Alzheimer's disease and other neurological and psychiatric disorders. Alzheon leverages precision medicine to create solutions that can significantly slow or halt the progression of these diseases. Their leading product, ALZ-801, is an oral anti-amyloid treatment currently in Phase testing, aimed at preventing the onset of clinical symptoms and preserving future memories.

Key figures in Alzheon include CEO Martin Tolar, MD, PhD, and Executive Chairman Neil Flanzraich. The company has garnered attention for its significant advancements in Alzheimer's research, particularly with ALZ-801. By focusing on well-tolerated treatments based on extensive research, Alzheon has made impactful strides in the pharmaceutical industry, offering hope to millions affected by neurological disorders. Their work has positioned them as a promising player in the fight against Alzheimer's disease.

Alzheon - Similar Companies

Alzeca Biosciences logo

Alzeca Biosciences

alzeca.com

Allyx Therapeutics logo

Allyx Therapeutics

allyxthera.com

Aztherapies logo

Aztherapies

Alkeus Pharmaceuticals logo

Alkeus Pharmaceuticals

alkeus.com

BioHealthonomics logo

BioHealthonomics

Alto Neuroscience logo

Alto Neuroscience

Intellect Neurosciences logo

Intellect Neurosciences

Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

amylyx.com

Neuraly logo

Neuraly

neuralymed.com

Alcyone Lifesciences logo

Alcyone Lifesciences

NeuroGenetic Pharmaceuticals logo

NeuroGenetic Pharmaceuticals

Alsp logo

Alsp

Amygdala Neurosciences logo

Amygdala Neurosciences

amygns.com

Alector logo

Alector

alector.com

Denali Therapeutics logo

Denali Therapeutics

Alzheon - Quick Facts

Who are Alzheon's competitors?

Companies similar to Alzheon include Alzeca Biosciences, Allyx Therapeutics, Aztherapies and Alkeus Pharmaceuticals.

When was Alzheon founded?

Alzheon was founded in 2013.

Where is Alzheon's headquarters located?

Alzheon's headquarters is located in Framingham, MA, US.

When was Alzheon's last funding round?

Alzheon's most recent funding round was for $1.7M (USD) in January 2023.

How much has Alzheon raised to-date?

As of Jan 11, 2023, Alzheon has raised a total of $140M (USD).

How many employees does Alzheon have?

Alzheon has 11 employees as of Feb 5, 2024.

Alzheon - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotechnology
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 19 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541310Architectural Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541300Architectural, Engineering, and Related Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8710Engineering, Architectural, And Surveying Services
  • 8712Architectural Services
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7110Architectural and engineering activities and related technical consultancy